Zobrazeno 1 - 10
of 209
pro vyhledávání: ''
Autor:
Stephen J. Greene, Evan M Murray, Muthiah Vaduganathan, Michael E. Nassif, Darren K. McGuire, Vishal N. Rao, Gregg C. Fonarow, JoAnn Lindenfeld, Kavita Sharma, Javed Butler, Robert J. Mentz, Neha J. Pagidipati, Zachary L. Cox, Lauren B. Cooper, Cara O'Brien, Mona Fiuzat, Jennifer B. Green, Orly Vardeny
Publikováno v:
J Am Coll Cardiol
Sodium-glucose cotransporter-2 inhibitor therapy is well suited for initiation during the heart failure hospitalization, owing to clinical benefits that accrue rapidly within days to weeks, a strong safety and tolerability profile, minimal to no effe
Publikováno v:
Journal of the American College of Cardiology. 78:1671-1678
Background SBP and DBP have important associations with cardiovascular events, but are seldom considered simultaneously. Objectives This study sought to simultaneously analyze systolic blood pressure (SBP) and diastolic blood pressure (DBP) measureme
Autor:
Marc A. Pfeffer, Felipe Martinez, Pardeep S. Jhund, Orly Vardeny, Michael R. Zile, Muthiah Vaduganathan, Jean L. Rouleau, Dirk J. van Veldhuisen, Karl Swedberg, Aldo P. Maggioni, Akshay S. Desai, Faiez Zannad, John J.V. McMurray, Milton Packer, Inder S. Anand, Li Shen, Ankeet S. Bhatt, Scott D. Solomon, Adel R. Rizkala
Publikováno v:
Journal of the American College of Cardiology, 77(16), 1961-1973. ELSEVIER SCIENCE INC
Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2021, 77 (16), pp.1961-1973. ⟨10.1016/j.jacc.2021.03.001⟩
Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2021, 77 (16), pp.1961-1973. ⟨10.1016/j.jacc.2021.03.001⟩
BACKGROUND The incidence of pneumonia and subsequent outcomes has not been compared in patients with heart failure and reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF).OBJECTIVES This study aimed to examine the rate and impac
Autor:
Marc S. Sabatine, Michael J. Koren, Stephen D. Wiviott, Andrew Hamer, Gisle Langslet, Yuhui Ma, Robert P. Giugliano, Frederick J. Raal, Andrea Ruzza, Scott M. Wasserman
Publikováno v:
Journal of the American College of Cardiology. 74:2132-2146
Background Evolocumab and other anti-PCSK9 antibodies reduced adverse cardiovascular outcomes in clinical trials of high-risk patients over Objectives The OSLER-1 trial (Open Label Study of Long Term Evaluation Against LDL-C Trial) evaluated longer-t
Autor:
Laura Gutiérrez García-Moreno, Luis Escobar-Lopez, María Gallego-Delgado, Maria Victoria Mogollón-Jimenez, María Ángeles Espinosa, Juan Pablo Ochoa, M N Brogger, Jesús G. Mirelis, Pablo García-Pavía, Juan Ramón Gimeno-Blanes, Juan Jiménez-Jáimez, Irene Méndez, María Alejandra Restrepo-Córdoba, Julián Palomino-Doza, Ana I. Fernández, José Manuel García-Pinilla, María Brion, Tomás Ripoll-Vera, Roberto Barriales-Villa, Vicente Climent, Marina Navarro, María Luisa Peña-Peña, Uxua Idiazabal, Esther Gonzalez-Lopez, Ana García-Álvarez, Ana Abecia, Eduardo Villacorta, Antoni Bayes-Genis, J F Rodriguez-Palomares, Ainhoa Robles-Mezcua, José M. Larrañaga-Moreira, Javier Lopez, Coloma Tiron, María Teresa Basurte-Elorz, María Sabater, Enrique Lara-Pezzi, Fernando Dominguez, Soledad García-Hernández
Publikováno v:
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Journal Of The American College Of Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Journal Of The American College Of Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
BACKGROUND The clinical relevance of genetic variants in nonischemic dilated cardiomyopathy (DCM) is unsettled. OBJECTIVES The study sought to assess the prognostic impact of disease-causing genetic variants in DCM. METHODS Baseline and longitudinal
Autor:
Tim Snijders, Neeltje A. E. Allard, Anouk A.F. Stoffels, Maria T. E. Hopman, Lando Janssen, Willem J. J. Assendelft, Thorben Aussieker, Richard J. Rodenburg, Silvie Timmers, Paul D. Thompson
Publikováno v:
Journal of the American College of Cardiology 78 (2021) 21
Journal of the American College of Cardiology, 78, 2023-2037
Journal of the American College of Cardiology, 78, 21, pp. 2023-2037
Journal of the American College of Cardiology, 78(21), 2023-2037. Elsevier Science
Journal of the American College of Cardiology, 78(21), 2023-2037
Journal of the American College of Cardiology, 78, 2023-2037
Journal of the American College of Cardiology, 78, 21, pp. 2023-2037
Journal of the American College of Cardiology, 78(21), 2023-2037. Elsevier Science
Journal of the American College of Cardiology, 78(21), 2023-2037
BACKGROUND The combination of statin therapy and physical activity reduces cardiovascular disease risk in patients with hyperlipidemia more than either treatment alone. However, mitochondrial dysfunction associated with statin treatment could attenua
Publikováno v:
Journal of the American College of Cardiology. 75:2644-2646
The 2017 American College of Cardiology/American Heart Association guideline proposes an aggressive approach to hypertension (HTN) management ([1][1]). The NHANES (National Health and Nutrition Examination Survey) study suggested that HTN-related car
Autor:
Alan Zajarias, Eric D. Peterson, E. Murat Tuzcu, Dadi Dai, Ralph G. Brindis, John D. Carroll, Frederick L. Grover, Fred H. Edwards, Michael J. Mack, Mohanad Hamandi, Brian R. Lindman, Molly Szerlip, Sean M. O'Brien, Vinod H. Thourani, Sreekanth Vemalapalli, Matthew Brennan, Dave Shahian, Hersh S. Maniar, John S. Rumsfeld, David R. Holmes
Publikováno v:
Journal of the American College of Cardiology. 73:2806-2815
In patients with end-stage renal disease (ESRD), surgical aortic valve replacement is associated with higher early and late mortality, and adverse outcomes compared with patients without renal disease. Transcatheter aortic valve replacement (TAVR) of
Autor:
Scot Garg, Rodrigo Modolo, Patrick W. Serruys, Robbert J. de Winter, Robert Zweiker, Mariusz Tomaniak, Michael Magro, Norihiro Kogame, Jan G.P. Tijssen, Marco Valgimigli, Christian W. Hamm, Kuniaki Takahashi, Philippe Gabriel Steg, Saqib Chowdhary, Pascal Vranckx, Hans-Peter Stoll, Didier Carrié, Paul Jau Lueng Ong, Ingo Eitel, Ply Chichareon, Joanna J. Wykrzykowska, Chun Chin Chang, Michael Mundt Ottesen, Yoshinobu Onuma, Stephan Windecker
Publikováno v:
Journal of the American College of Cardiology, 74(16), 2015-2027. Elsevier Inc.
Journal of the American College of Cardiology, 74(16), 2015-2027. Elsevier USA
Journal of the American College of Cardiology, 74(16), 2015-2027. Elsevier USA
Background: Data on optimal antiplatelet treatment regimens in patients who undergo multivessel percutaneous coronary intervention (PCI) are sparse. Objectives: This post hoc study investigated the impact of an experimental strategy (1-month dual ant
Autor:
Laura Landucci, Daniel P. Andersson, Mikael Lehtihet, Martin J. Holzmann, Alessandra Grotta, Ylva Trolle Lagerros, Rino Bellocco
Publikováno v:
Journal of the American College of Cardiology. 77(12)
Background Phosphodiesterase 5 inhibitor (PDE5i) treatment is associated with reduced mortality compared with no treatment for erectile dysfunction after myocardial infarction (MI). Objectives This study sought to investigate the association between